Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.
Recruiting
Observational Study
Pregnancy Related
Heart Rate Variation (HRV)
Hemodynamics
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 242 (estimated)
- Sponsor
- Fundacin Biomedica Galicia Sur · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Heart rate variability (HRV) provides a non-invasive assessment of autonomic control of the nervous system over the heart. During pregnancy, the cardiovascular system adapts significantly, affecting HRV and hemodynamics. Studying the relationship between HRV and hemodynamic changes is critical to understanding and monitoring cardiovascular health during pregnancy and postpartum, and predicting pot…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Over 18 years of age
* Pregnancy from the third month of gestation
* No pre-existing cardiovascular disease
* Good cognitive level
* Sign informed consent
Exclusion Criteria:
* Diabetes mellitus
* Hyperthyroidism
* Hypothyroidism
* Chronic hypertension diagnosed before pregn…
Contacts